Dr. Badhwar’s credentials are formidable, reflecting more than two decades of comprehensive clinical, research, and administrative expertise. His role as Executive Chair of the West Virginia University (WVU) Heart and Vascular Institute and his stewardship as Professor and Chair of the Department of Cardiovascular and Thoracic Surgery at WVU underscore his depth in surgical innovation and organizational leadership. His presidency signals a commitment to integrating cutting-edge surgical techniques with multidisciplinary collaboration, harmonizing clinical excellence with emergent scientific discoveries.

The framework guiding Dr. Badhwar’s presidency revolves around three fundamental pillars—Excellence, Evidence, and Impact—each extending beyond mere ideals to encapsulate the core identity and mission of cardiothoracic surgery. “Excellence” spotlights the unyielding demand for technical mastery in the operating room, emphasizing reproducible outcomes that prioritize patient safety and efficacy. Dr. Badhwar envisions a standard where complex and minimally invasive procedures reach unprecedented levels of precision through augmented training and technological incorporation.

Simultaneously, “Evidence” underscores the indispensability of rigorous data acquisition, advanced analytics, and innovative research methodologies to enhance clinical decision-making. STS, under his guidance, aims to propel the use of its comprehensive National Database by advancing machine learning applications and real-world evidence to validate emerging surgical techniques and devices. This integration of empirical science will form the backbone of therapeutic innovation and healthcare policy advancements.

“Impact,” the third pillar, reflects a holistic approach to measurable outcomes extending beyond survival rates to encompass quality of life, functional recovery, and long-term benefits for patients and families. Dr. Badhwar stresses that impact must also be gauged within the broader healthcare system by analyzing cost-effectiveness, accessibility, and interdisciplinary cooperation. His leadership philosophy calls for surgeons to assume active roles in shaping healthcare delivery models that optimize resource utilization without compromising care quality.

Dr. Badhwar’s expertise in robotic cardiac surgery marks him as a pioneer in a field that is revolutionizing surgical practice by leveraging robotic precision, haptics, and enhanced visualization. His extensive scholarly contributions include over 400 peer-reviewed publications and eight patents that signify his commitment to advancing cardiovascular technology through innovation. These innovations have substantially influenced minimally invasive valve reconstruction and replacement procedures, reducing morbidity and hospital stays.

His academic journey through some of North America’s leading institutions, including McGill University, the University of Ottawa, and the University of Michigan, laid the foundation for his surgical and research acumen. His tenure as Chief of Adult Cardiac Surgery at the University of Pittsburgh enriched his leadership experience and clinical expertise, balancing high-volume surgical practice with robust research initiatives.

Since 2016, as head of WVU’s cardiovascular service line, Dr. Badhwar has overseen a complex, large-scale healthcare ecosystem with over 250 providers and 1,500 employees, managing operational budgets surpassing $2 billion. His leadership at WVU illustrates his capacity to integrate cutting-edge clinical programs with expansive academic research and healthcare delivery systems, promoting innovative cardiovascular care including one of the nation’s leading robotic cardiac surgery programs.

Addressing the audience at STS 2026, Dr. Badhwar articulated the necessity for interdisciplinary collaboration across surgical subspecialties, medical disciplines, health system administrators, and policymakers. He projected that the future of cardiothoracic surgery hinges not only on surgical skills but on the capacity to lead integrative, patient-centered teams driving systemic improvement in healthcare quality and outcomes.

Emphasizing the dynamic nature of modern cardiothoracic surgery, Dr. Badhwar called for a culture of continuous learning and adaptability. His vision is to cultivate an environment where surgical innovation aligns with empirical evidence and patient-centered metrics, thus ensuring the specialty remains at the forefront of healthcare innovation.

Beyond his surgical and research accolades, Dr. Badhwar continues to enrich academic discourse as a Senior Editor for The Annals of Thoracic Surgery, shaping the publication of pivotal research that defines surgical standards and emerging trends across the specialty.

His presidency begins at a critical time when cardiothoracic surgery faces transformative changes driven by new biomaterials, robotic platforms, and data science, all converging to expand therapeutic possibilities and improve patient safety. Dr. Badhwar’s leadership promises to catalyze STS’s role as a beacon of innovation, scientific rigor, and compassionate care in the global cardiothoracic surgery community.

At the 2026 Annual Membership Meeting, alongside Dr. Badhwar’s election as President, the organization also elected Vinod Thourani, MD, as First Vice President; Jessica Donington, MD, as Second Vice President; Wilson Szeto, MD, as Secretary (re-elected); Joseph Cleveland Jr., MD, as Secretary-Elect; and John Mitchell, MD, as Treasurer (re-elected). This leadership team is poised to advance the Society’s mission amid ongoing healthcare challenges and technological advancements.

The Society of Thoracic Surgeons itself stands as the largest nonprofit organization globally representing over 8,000 professionals dedicated to advancing cardiothoracic surgery. Its robust STS National Database is among the most comprehensive clinical registries, enabling ongoing research, education, advocacy, and clinical quality improvement efforts that define the highest standards of patient care internationally.

With Dr. Vinay Badhwar’s presidency, the STS is set to reinforce its legacy of surgical excellence while embracing evolved models of evidence-based practice and impactful patient-centered care, ensuring the specialty adapts and thrives in the coming decades.

Subject of Research: Cardiothoracic surgery leadership and clinical innovation
Article Title: Vinay Badhwar, MD, Elected 62nd President of The Society of Thoracic Surgeons, Champions Excellence and Innovation
News Publication Date: January 31, 2026
Web References: https://mediasvc.eurekalert.org/Api/v1/Multimedia/6c63afeb-fb1a-4145-ad57-de051a3ec26c/Rendition/low-res/Content/Public
Image Credits: STS
Keywords: Health and medicine, Vascular diseases, Cardiovascular disorders, Cancer, Lung cancer

A pioneering study led by researchers at the University of Michigan unveils a paradigm-shifting approach aimed at optimizing pre-operative testing by tailoring strategies to reduce unnecessary examinations without compromising patient safety. This strategy, encapsulated in the “Right-Sizing Testing Before Elective Surgery” program, abbreviated as RITE-Size, represents a carefully calibrated intervention tailored to each hospital’s unique clinical environment. The program’s inception responds to a critical healthcare challenge: the persistence of unwarranted pre-surgical testing that adds healthcare costs, patient inconvenience, and system inefficiencies without improving the clinical course.

The motivation for this research stems from the observation that many routine pre-surgical tests do not inform or alter perioperative management in healthy patients undergoing low-risk procedures such as laparoscopic cholecystectomy, inguinal hernia repair, or breast lumpectomy. Data from three distinct hospitals—two community-based in smaller urban centers and one academically affiliated in a midsize city—revealed an initial baseline wherein an astonishing 68% of ostensibly low-risk patients underwent one or more unnecessary diagnostic tests. This prevalence underscores a systemic inclination toward defensive medicine and entrenched clinical habits that may not align with contemporary evidence-based guidelines.

The RITE-Size initiative embarked on a multipronged, data-informed campaign to foster sustainable change. By first conducting granular analyses into the utilization patterns of eleven commonly performed tests—including cardiac stress evaluations, pulmonary function tests, and coagulation studies—the team gained insights into local clinical decision-making determinants. Following this diagnostic phase, the intervention deployed targeted education, iterative coaching, and continuous feedback loops involving the multidisciplinary perioperative care teams, notably incorporating pre-operative nursing staff whose roles were pivotal to the successful implementation. The strategic inclusion of nursing perspectives acknowledged the underestimated influence these professionals exert in care pathways, as emphasized in an accompanying expert commentary from Stanford University.

Remarkably, the program’s impact was both rapid and durable. Within a mere six months, the frequency of low-value testing declined by approximately 40%, a dramatic improvement corroborated by objective testing data. One of the three hospitals successfully nearly eliminated wasteful pre-operative testing during a portion of the intervention, showcasing the profound influence of tailored educational interventions grounded in institutional context. Such results not only alleviate patient burden but also promise substantial economic benefits by curbing unnecessary healthcare expenditure. These findings hold considerable significance amidst increasing pressures to enhance the value and efficiency of surgical care delivery.

The roots of this research extend back to prior work by the Michigan Program on Value Enhancement (MPrOVE), a collaborative enterprise bridging the U-M Institute for Healthcare Policy and Innovation and Michigan Medicine’s academic medical center. Earlier phases targeted a more limited subset of pre-operative tests and were confined to the U-M Health system. The current study broadens the scope dramatically, encompassing multiple community sites and an expanded array of diagnostic modalities. This scaling reflects both the robustness of the intervention’s framework and the growing recognition of the need to contextualize recommendations within diverse practice environments.

The methodologies employed in RITE-Size epitomize a sophisticated interplay between data analytics, behavioral science, and systems engineering applied to healthcare. By periodically disseminating customized reports, the team empowered clinicians to visualize their test-ordering trends against benchmarks, fostering self-correction and peer-supported accountability. Clinical leaders and pre-operative teams participated in ongoing dialogues to identify barriers and facilitators, allowing the program to dynamically adapt and resonate with frontline providers’ realities. This iterative, feedback-rich approach starkly contrasts with traditional top-down mandates, illustrating how granular, human-centered strategies can drive meaningful quality improvement.

Importantly, the overarching narrative challenges the longstanding dogma of routine pre-operative testing in low-risk surgical candidates. Current guidelines have increasingly cautioned against blanket testing, advocating for a more selective, patient-tailored approach. However, real-world adherence has lagged due to factors such as medico-legal concerns, historical clinical inertia, and fragmented care coordination. This study offers compelling evidence that through nuanced, targeted, and inclusive interventions, entrenched practices can shift substantially toward higher-value care models that prioritize patient safety without waste.

The implications of this work reverberate beyond the three pilot hospitals. Buoyed by demonstrable successes, the RITE-Size program is slated to scale across sixteen additional Michigan hospitals over the ensuing years. This expansion, supported by the Michigan Surgical Quality Collaborative, the Michigan Value Collaborative, and another perioperative quality network called ASPIRE, leverages existing collaborative infrastructures that foster knowledge sharing and comparative benchmarking. Through such concerted collective action, the initiative seeks not only to transform pre-operative testing practices regionally but also to set a blueprint for analogous endeavors nationally and internationally.

Beyond operational impacts, this research resonates within the broader discourse on sustainability and stewardship in healthcare. By effectively addressing overuse, the program exemplifies an ethically and economically responsible approach to resource utilization. Patients spared unnecessary tests avoid potential downstream consequences such as false positives, anxiety, and procedural delays. Additionally, healthcare systems can redirect saved resources toward more clinically impactful initiatives. This alignment of clinical prudence, patient-centeredness, and value-based care encapsulates the evolving ethos of modern healthcare innovation.

As the healthcare community digests and builds upon these findings, the study underscores the vital role of interdisciplinary collaboration in driving change. Surgeons, anesthesiologists, nurses, administrators, and data scientists must coordinate synergistically to dismantle outdated paradigms and implement evidence-based best practices. The RITE-Size model, characterized by its inclusivity and responsiveness to institutional culture, offers a replicable template. By intricately weaving education, data feedback, and stakeholder engagement, it shines a light on pathways to diminish low-value care while enhancing outcomes and patient satisfaction.

In summation, the University of Michigan-led investigation decisively illustrates that right-sizing pre-operative testing for low-risk elective surgeries is not only feasible but yields profound benefits in reducing inefficiencies and optimizing patient care. By identifying and addressing the nuances of institutional behavior, leveraging multidisciplinary engagement, and deploying iterative learning frameworks, RITE-Size charts an innovative course toward smarter surgical preparation. As this initiative scales and informs future quality improvement endeavors, it heralds a new era where precision in testing complements precision in surgery, ultimately fostering a more rational, humane, and effective healthcare system.

Subject of Research: People

Article Title: Right-Sizing Testing Before Elective Surgery for Patients With Low Risk

News Publication Date: 6-Oct-2025

Web References:
https://jamanetwork.com/journals/jamanetworkopen/fullarticle/10.1001/jamanetworkopen.2025.35750

References:
Mott N, Dossett L, et al. Right-Sizing Testing Before Elective Surgery for Patients With Low Risk. JAMA Network Open. 2025.

Keywords: Surgery; Surgical procedures; Diagnostic imaging; Medical tests; Electrocardiography; Breast cancer; Hospitals; Health care delivery; Health care costs; Anesthesiology